PURPLE BIOTECH LTD.(PPBT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $1.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
PPBT Stock Analysis & AI Quality Score
AI stock analysis and institutional research for PURPLE BIOTECH LTD. (PPBT), a Healthcare sector company. PPBT is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $1.0m in revenue. Based on the latest XBRL financial filings (FY 2020), PURPLE BIOTECH LTD. reports quarterly revenue of $1.0M, net income of $28.1M. Top institutional holders of PPBT by reported 13-F value include SUSQUEHANNA INTERNATIONAL GROUP, LLP, SmartHarvest Portfolios,, BNP PARIBAS FINANCIAL MARKETS, based on the most recent SEC filings. PPBT trades on the Nasdaq exchange and files with the SEC under CIK 1614744. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PPBT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PURPLE BIOTECH LTD. directly from SEC EDGAR.
Revenue
FY 2020
$1.0M
Net Income
FY 2020
$28.1M
Get alerted when PPBT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for PURPLE BIOTECH LTD. including:
Top Institutional Holders of PPBT
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$215.7K53,403 shSmartHarvest Portfolios, LLC
$73.2K18,127 shBNP PARIBAS FINANCIAL MARKETS
$7.9K1,957 shRHUMBLINE ADVISERS
$2.9K710 shSIMPLEX TRADING, LLC
$2.4K597 shMORGAN STANLEY
$2.3K578 shGAMMA Investing LLC
$436.00108 shUBS Group AG
$400.0099 shSBI Securities Co., Ltd.
$125.0031 shGROUP ONE TRADING, L.P.
$81.0020 sh
| Fund | Value | Shares |
|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $215.7K | 53,403 |
| SmartHarvest Portfolios, LLC | $73.2K | 18,127 |
| BNP PARIBAS FINANCIAL MARKETS | $7.9K | 1,957 |
| RHUMBLINE ADVISERS | $2.9K | 710 |
| SIMPLEX TRADING, LLC | $2.4K | 597 |
| MORGAN STANLEY | $2.3K | 578 |
| GAMMA Investing LLC | $436.00 | 108 |
| UBS Group AG | $400.00 | 99 |
| SBI Securities Co., Ltd. | $125.00 | 31 |
| GROUP ONE TRADING, L.P. | $81.00 | 20 |
More Healthcare Companies
View all Healthcare →Put PPBT on your watchlist
Track score changes the day PURPLE BIOTECH LTD. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is PPBT a good stock to buy?
13F Pro's AI-powered analysis of PURPLE BIOTECH LTD. (PPBT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PPBT are available on the PPBT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own PPBT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PPBT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of PURPLE BIOTECH LTD.'s investment landscape.